Industry News
Prima names new advisors for CVac programs
Prima BioMed (ASX:PRR) has appointed oncology experts Dr Holbrook Kohrt and Dr Pamela Klein as clinical advisors for its cancer vaccine programs. [ + ]
Chief Scientist urges more thought for the future
The importance of science to Australia’s future and its place in the world will be the subject of a free public lecture in Perth next month by Australia’s Chief Scientist, Professor Ian Chubb. [ + ]
Leading scientific experts appointed to Carbon Farming Committee
The Parliamentary Secretary for Climate Change, Industry and Innovation, Yvette D’Ath, today appointed Dr Tony Press, CEO of the Australian Antarctic Climate and Ecosystems Cooperative Research Centre, as Chair of the Domestic Offsets Integrity Committee. D’Ath also appointed Noel Peters as a new member of the committee. [ + ]
Discovery of three new molecules opens door for breast, prostate cancer treatments
A team of Western Australian cancer researchers interested in the strong link between hormones and cancer have discovered three new molecules that may have an important role to play in future breast and prostate cancer treatments. [ + ]
Alchemia lands discovery deal with AstraZeneca
Alchemia (ASX:ACL) has entered a small molecule drug discovery collaboration with AstraZeneca based on the former’s VAST chemistry platform. [ + ]
Bionomics initiates manufacturing of tumour drug
Bionomics (ASX:BNO) has contracted Lonza to produce tumour drug candidate BNC101 ahead of clinical trials anticipated for 2014. [ + ]
New immune cell in skin
A new type of immune cell in skin that is involved in warding off parasites could be linked to eczema and allergic skin diseases. [ + ]
Registration deadline looming for R&D Tax Incentive
The registration of research and development (R&D) activities, under the R&D Tax Incentive, closes next week for the 2011-12 year. [ + ]
Reigniting cell death
Australian researchers have taken an important step towards designing a potential new anticancer agent. [ + ]
Ultrafast high-resolution imaging in real time
Ultrafast high-resolution imaging in real time could be a reality with a new research discovery led by the University of Melbourne. [ + ]
Spectral patterns of benzene dimer finally deciphered
A spectrum of the benzene dimer was first recorded in 1993, with the aim to find out more about its structure and dynamics. The experiments produced characteristic patterns with four peaks, which no one could decipher for 20 years. Now, using a new theoretical model and the experimental data gathered in Berlin, the spectral patterns have been successfully deciphered and the dynamics that cause them explained. [ + ]
Developing a faster diagnosis of bacterial meningitis
Using joint funding from the Paige Weatherspoon Foundation and the Macquarie University Office of Commercialisation, a team of researchers have recently made headway in developing a faster diagnosis for bacterial meningitis. [ + ]
Swedish agencies to trial Bioniche E. coli vaccine
Swedish government agencies will incorporate Bioniche’s (ASX:BNC) E. coli O157 cattle vaccine in its research into limiting human infection by verotoxigenic E. coli. [ + ]
AmpliPhi, Intrexon team for bacteriophage projects
AmpliPhi and synthetic biology company Intrexon will collaborate on bacteriophage treatments for antibiotic-resistant infections. [ + ]
Novel technology for targeted NGS in large numbers of samples
Researchers at Population Genetics Technologies (Cambridge, UK) have developed and validated an innovative technology - Reflex - for efficient targeted sequencing of long DNA regions in large numbers of genomic DNA samples. [ + ]